COG AALL1122 (BMS CA180-372): A Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib (IND# 66,971) Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome...

      Project: Research project

      Project Details

      StatusFinished
      Effective start/end date8/15/128/31/15

      Funding

      • Children's Hospital of Philadelphia